A novel kinetic cholinesterase-inhibition based method for quantification of biperiden in pharmaceutical preparations

Vladan R. Djurić, Violeta D. Mitić, Nebojša R Deletić, Marija D. Ilić, Bratislav M. Ćirković, Vesna P. Stankov-Jovanović

Abstract


Biperiden, an antiparkinsonian anticholinergic drug, has been found to inhibit enzymatic hydrolysis of butyrylthiocholine iodide, which is catalyzed by serum cholinesterase. By measuring the difference in the basic and inhibitory hydrolysis reaction rates, in the presence of biperiden as an inhibitor, it is possible to develop a kinetic method for its determination. Both systems, enzyme-substrate-chromogen and enzyme-substrate-chromogen-inhibitor, were characterized by biochemical parameters (KM = 0.326 – 0.330 mmol dm-3; Vmax = 40 ‑ 99 μmol dm-3 min-1), while inhibition was defined as non-competitive with the constant of inhibition Ki = 6.142 μmol dm-3. The reaction conditions have been optimized followed by determination of the calibration curve, the corresponding equation and the limits of detection and quantification yielding 3.84 and 12.80 nmol dm-3, respectively. Using the calibration chart, it is possible to determine biperiden in different samples in the concentration range of 0.035–35.940 µmol dm-3. Influence of a number of substances, found in the sample, on the reaction rate was also examined. The optimized method was applied for determination of biperiden in pharmaceutical preparations. Accuracy of the method was tested using the standard addition method. The proposed method has good sensitivity, selectivity, it is simple and fast, and above all easily accessible, and thus applicable in biochemical and pharmaceutical laboratories.


Keywords


enzyme; hydrolysis; inhibition; butyrylthiocholine iodide; reaction rate; optimization

References


Shih TM, McDonough JH. Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication. Arch Toxicol. 2000; 74:165–172.

Minakata K, Yamagishi I, Nozawa H, Hasegawa K, Suzuki M, Gonmori K, Suzuki O. Quantitation of biperiden in whole blood by MALDI-QTOF tandem mass spectrometry, and estimation of new metabolites in urine of deceased subjects treated with biperiden antemortem. Forensic Toxicol. 2017; 35:86–93.

Yokogawa K, Nakashima E, Ichimura F, Yamana T. Simultaneous microdetermination of biperiden, haloperidol, and trihexyphenidyl in plasma and its application to pharmacokinetic analysis after concomitant intravenous administration of the drugs to rabbits. Chem Pharm Bull (Tokyo). 1985; 33:4581–4586.

Hadidi KA. Development of a screening method for the most commonly abused anticholinergic drugs in Jordan; trihexyphenidyl, procyclidine and biperiden. Leg Med (Tokyo). 2004; 6:233–241.

Čápka V, Xu Y. Simultaneous determination of enantiomers of structurally related anticholinergic analogs in human serum by liquid chromatography–electrospray ionization mass spectrometry with on-line sample cleanup. J Chrom B: Biomed Sci Appl. 2001; 762:181–192.

Khaled E, Hassan HNA, Ahmed MA, El‐Attar RO. Crown ether/carbon nanotubes based biperiden disposable potentiometric sensor. Electoanalysis. 2017; 29:975–982.

Samanidou V, Stathatos C, Njau S, Kovatsi L. Disposable pipette extraction for the simultaneous determination of biperiden and three antipsychotic drugs in human urine by GC–nitrogen phosphorus detection. Bioanalysis. 2013; 5:21–29.

Mohammadi A, Mehramizi A, Aghaee Moghaddam F, Erfani Jabarian L, Pourfarzib M, Kashani HN. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms. J Chrom B: Biomed Sci Appl. 2007; 854:152–157.

Mandrioli R, Musenga A, Lasaponara SS, Saracino MA, Fanali S, Raggi MA. Enantioseparation and quality control of biperiden in pharmaceutical formulations by capillary electrophoresis. Anal Chim Acta. 2006; 560:57–63.

Issa FAA, EL-Helbawy SM, Abed EL-Magied AM. Simultaneous determination of some anticholinergic drugs (biperiden and chlorphenoxamine) in various dosage forms by spectrophotometry. International Journal of Chemical and Analytical Science. 2012; 3:1296–1300.

Stankov-Jovanović VP, Nikolić-Mandić SD, Mandić LjM, Mitić VD. Cholinesterase inhibition based determination of pancuronium bromide in biological samples. Anal Bioanal Chem. 2006; 385:1462–1469.

www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50240680 (accessed March 27, 2020)

Stankov-Jovanović VP, Nikolić-Mandić SD, Mandić LjM, Mitić VD. A modification of the kinetic determination of pancuronium bromide based on its inhibitory effect on cholinesterase. J Clin Lab Anal. 2007; 21:124–131.

Yatsimirskii KB (Ed.) Kinetic Methods of Analysis. 2nd ed. Moscow, USSR: Khimiya; 1967; p.55–56.

Miller JC, Miller JN. Statistics for Analytical Chemistry. New York, NY: John Wiley & Sons; 1984.

Kirkbright GF. Development and publication of new spectro-photometric methods of analysis. Talanta. 1966; 13:1–14.




DOI: https://doi.org/10.2298/HEMIND200413021D

Copyright (c) 2020 HEMIJSKA INDUSTRIJA

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.